Mao-Wang Ho
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 6
- Antimicrobial Resistance in Staphylococcus 4
- HIV/AIDS drug development and treatment 4
- Molecular Medicine top 10%
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing 4
- Epidemiology top 10%
- Fungal Infections and Studies 5
- Pneumocystis jirovecii pneumonia detection and treatment 3
-
- HIV Research and Treatment 3
-
- Bacterial biofilms and quorum sensing 3
- Co-authors
- Chi‐Yuan LiCheng‐Mao HoJang‐Jih LuJen-Hsien WangCheng‐Lung KuChia-Hao LinChih‐Ho LaiC.C. Chu
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Mao-Wang Ho
24 papers receiving 600 citations
Peers
Comparison fields: 5 of 79
- Infectious Diseases 341
- Applied Microbiology and Biotechnology 33
- Molecular Medicine 71
- Clinical Biochemistry 60
- Epidemiology 293
Countries citing papers authored by Mao-Wang Ho
This map shows the geographic impact of Mao-Wang Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mao-Wang Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mao-Wang Ho more than expected).
Fields of papers citing papers by Mao-Wang Ho
This network shows the impact of papers produced by Mao-Wang Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mao-Wang Ho. The network helps show where Mao-Wang Ho may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mao-Wang Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2019 | 6 | |
| 7 | 2018 | 42 | |
| 8 | 2018 | 7 | |
| 9 | 2017 | 13 | |
| 10 | 2015 | 4 | |
| 11 | 2014 | 5 | |
| 12 | 2013 | 8 | |
| 13 | 2012 | 17 | |
| 14 | 2012 | 42 | |
| 15 | 2011 | 8 | |
| 16 | 2011 | 23 | |
| 17 | 2010 | 39 | |
| 18 | 2009 | 18 | |
| 19 | 2008 | 47 | |
| 20 | Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections. | 2001 | 4 |
About Mao-Wang Ho
Mao-Wang Ho is a scholar working on Applied Microbiology and Biotechnology, Virology and Infectious Diseases, having authored 28 papers that have together received 614 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Bacterial biofilms and quorum sensing (3 papers). The work is most often cited by research in Infectious Diseases (341 citations), Applied Microbiology and Biotechnology (33 citations) and Molecular Medicine (71 citations). Mao-Wang Ho has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Chi‐Yuan Li, Cheng‐Mao Ho, Jang‐Jih Lu, Jen-Hsien Wang, Cheng‐Lung Ku, Chia-Hao Lin, Chih‐Ho Lai, C.C. Chu, Hung‐Jen Chen and Yuh‐Pyng Sher. Their work appears in journals such as Blood, PLoS ONE and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.